Enhancing the QUAlity and Transparency Of health Research
The following guidelines are currently being developed:
Please email us to register the development of your guideline to prevent duplication of effort.
PRISMA-P aims to provide guidance to those developing protocols for systematic reviews, positioned to be used by reviewers prior to carrying out a systematic review. Development of a systematic review protocol will facilitate protocol registration and publication if desired. The PRISMA-P Statement and Elaboration were submitted for publication in the Summer of 2014.
PRISMA Harms will extend the PRISMA Statement to improve harms reporting in systematic reviews and to encourage a more balanced assessment of the benefits and harms of interventions.
An official extension of the CONSORT 2010 Statement for reporting randomised controlled trials of social and psychological interventions is currently under development. A Delphi process to generate possible reporting standards for the guideline will take place in Fall 2013. Interested stakeholders should contact the project team to get involved in the development and dissemination of the guideline.
An official extension of the CONSORT 2010 Statement is underway for reporting N-of-1 trials. This guidance provides a set of essential items to include when preparing reports of prospectively planned, multiple crossover single patient trials, which may or may not be randomized. The CENT guidelines were submitted for publication in the Summer of 2014.
To develop reporting guidelines for observational studies using health data routinely collected for non-research purposes as an extension of the STROBE statement.
The STROBE Group have recently developed a checklist for conference abstracts. The draft STROBE checklist for abstracts is currently being piloted at the ECCMID conference.
To develop guidelines for the reporting of Respondent Driven Sampling studies. Adapted from the STROBE guidelines for cross-sectional studies.
This project aims to produce a set of quality criteria and comparable reporting guidance specifically for common neurological disorders.
Development of a guideline to improve the quality of reporting of Phase IV implementation studies, specifically those with a comparator group.
Bioresources (biological collections, biobanks and biological databases in particular) are increasingly important in research and need to be recognised and their use traced. Their citation in publications is a major way to achieve this but standardisation is required. The ongoing international BRIF (Bioresource research impact factor) initiative aims to find solutions to help address these issues. The BRIF subgroup’s (Members: A. Cambon Thomsen; E. Bravo; P. De Castro; A. Calzolari; L. Mabile; F. Napolitano; A.M. Rossi) workshop with journal editors held in June 2013 at the Istituto superiore di sanità in Rome, led to the first practical and realistic proposals for harmonising bioresources citations in journal articles.
Development of new guidelines for the reporting of meta-ethnography qualitative evidence syntheses.
Development of a checklist that can be used to report nutrition epidemiology.
Case series make up a large portion of the medical literature. This project aims to develop a checklist and guidance document for authors to improve the quality of reporting case series. The literature search is currently ongoing.
Development of essential reporting items for practice guidelines in health systems to ensure the comprehensive and transparent reporting of such guidelines.
Aim: To develop a reporting guideline for pilot and feasibility studies in preparation for a randomized controlled trial; as an extension to the CONSORT Statement.
The IDEAL (Idea, Development, Exploration, Assessment and Long term follow up) framework (1) allows for the phased and sequential development of a new surgical innovation, optimizing patient safety as the evidence-base builds in a controlled and purposeful manner.
These guidelines aim to improve the completeness of reports and protocols for IDEAL Prospective Development Studies (PDS – phase 2a) and Prospective Exploration Studies (PES – phase 2b).
1. McCulloch P, Altman DG, Campbell WB, et al, for the Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009; 374: 1105–12.
This project aims to develop a checklist to establish what information and how it should be presented in updated guidelines.
To develop an extension to the reporting guideline for parallel cluster trials to produce recommended reporting guidelines for stepped wedge cluster randomised controlled trials.
An official extension of the CONSORT 2010 Statement for reporting equity focused randomised controlled trials is currently under development.
The ClinPK guideline is an expert consensus-based guidance document and a checklist for reporting clinical pharmacokinetic studies. It is anticipated to be submitted for publication in the Summer of 2014.
When guideline development is completed and the guideline is published we will remove it from this list and include it in our database of reporting guidelines.
Please let us know about relevant projects; it will avoid duplication of the process and might also help you to find new collaborators.
Page last updated on: 17 September 2014
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.